share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.

Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%)等

SEC announcement ·  02/14 17:49
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息